Udg Healthcare (UDG) Stock Rating Reaffirmed by Peel Hunt
Udg Healthcare (LON:UDG)‘s stock had its “add” rating reissued by equities researchers at Peel Hunt in a note issued to investors on Tuesday. They currently have a GBX 880 ($11.84) price objective on the stock. Peel Hunt’s price target would suggest a potential upside of 6.34% from the company’s current price.
Other equities analysts also recently issued reports about the company. N+1 Singer raised their price objective on Udg Healthcare from GBX 770 ($10.36) to GBX 841 ($11.32) and gave the stock a “hold” rating in a research report on Wednesday, November 1st. Jefferies Group raised their price objective on Udg Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the stock a “hold” rating in a research report on Wednesday, October 4th. Stifel Nicolaus restated a “hold” rating and set a GBX 815 ($10.97) price objective on shares of Udg Healthcare in a research report on Thursday, November 30th. Liberum Capital reaffirmed a “hold” rating and set a GBX 884 ($11.90) target price on shares of Udg Healthcare in a research note on Tuesday, November 28th. Finally, Numis Securities cut Udg Healthcare to a “reduce” rating and set a GBX 765 ($10.30) target price for the company. in a research note on Thursday, November 9th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of GBX 826.43 ($11.12).
Udg Healthcare (UDG) opened at GBX 827.50 ($11.14) on Tuesday. Udg Healthcare has a 1 year low of GBX 632.50 ($8.51) and a 1 year high of GBX 963 ($12.96).
COPYRIGHT VIOLATION WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/21/udg-healthcare-udg-stock-rating-reaffirmed-by-peel-hunt.html.
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.